Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Metabolic disease involving other neurotransmitter deficiency
Butyrylcholinesterase deficiency
Butyrylcholinesterase (BChE) deficiency is a metabolic disorder characterized by prolonged apnoea after the use of certain anesthetic drugs, including the muscle relaxants succinylcholine or mivacurium and other ester local anesthetics. The duration of the prolonged apnoea varies significantly depending on the extent of the enzyme deficiency.
This condition has no sub-types.